Literature DB >> 7484098

Polymerase chain reaction fiber analysis and somatic mosaicism in autopsied tissue from a man with Duchenne muscular dystrophy.

M Uchino1, M Tokunaga, T Yamashita, S Mita, A Hara, E Uyama, H Teramoto, H Naoe, M Ando.   

Abstract

Single muscle fibers, obtained at autopsy from a 22-year-old man with Duchenne muscular dystrophy were examined immunocytochemically and also using polymerase chain reaction (PCR). Dystrophin-positive cells were widespread in skeletal, cardiac, smooth muscle, and in brain cells. PCR and Southern blot analyses of DNA from peripheral blood lymphocytes revealed a deletion of exon 45 in the dystrophin gene. With PCR of single fibers, three bands corresponding to exons 44, 45, and 47 were present in the normal control muscle fibers and dystrophin-positive fibers from the patient, while only two bands, exons 44 and 47, were observed in dystrophin-negative fibers. Therefore, in this patient, the genotype of dystrophin-positive fibers differed from that of the dystrophin-negative fibers, possibly because of a somatic mosaicism for deletion in the dystrophin gene. A mutation of the dystrophin gene may have occurred in one cell at an early stage of ontogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7484098     DOI: 10.1007/bf00294322

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  23 in total

1.  Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses.

Authors:  K Arahata; E P Hoffman; L M Kunkel; S Ishiura; T Tsukahara; T Ishihara; N Sunohara; I Nonaka; E Ozawa; H Sugita
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

2.  PCR and immunocytochemical analyses of dystrophin-positive fibers in Duchenne muscular dystrophy.

Authors:  M Uchino; M Tokunaga; S Mita; E Uyama; Y Ando; H Teramoto; T Miike; M Ando
Journal:  J Neurol Sci       Date:  1995-03       Impact factor: 3.181

3.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

4.  Dystrophin and dystrophin-related protein in the brains of normal and mdx mice.

Authors:  M Uchino; K Yoshioka; T Miike; M Tokunaga; E Uyama; H Teramoto; H Naoe; M Ando
Journal:  Muscle Nerve       Date:  1994-05       Impact factor: 3.217

5.  Insertion of a 5' truncated L1 element into the 3' end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy.

Authors:  N Narita; H Nishio; Y Kitoh; Y Ishikawa; Y Ishikawa; R Minami; H Nakamura; M Matsuo
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle.

Authors:  E E Zubrzycka-Gaarn; D E Bulman; G Karpati; A H Burghes; B Belfall; H J Klamut; J Talbot; R S Hodges; P N Ray; R G Worton
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

7.  Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide.

Authors:  K Arahata; S Ishiura; T Ishiguro; T Tsukahara; Y Suhara; C Eguchi; T Ishihara; I Nonaka; E Ozawa; H Sugita
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

8.  Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy.

Authors:  L V Nicholson; K Davison; M A Johnson; C R Slater; C Young; S Bhattacharya; D Gardner-Medwin; J B Harris
Journal:  J Neurol Sci       Date:  1989-12       Impact factor: 3.181

9.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene.

Authors:  A P Monaco; R L Neve; C Colletti-Feener; C J Bertelson; D M Kurnit; L M Kunkel
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

10.  Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification.

Authors:  J S Chamberlain; R A Gibbs; J E Ranier; P N Nguyen; C T Caskey
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

View more
  2 in total

1.  The clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: an updated protocol.

Authors:  A J van Essen; A L Kneppers; A H van der Hout; H Scheffer; I B Ginjaar; L P ten Kate; G J van Ommen; C H Buys; E Bakker
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

2.  Somatic mosaicism for Duchenne dystrophy: evidence for genetic normalization mitigating muscle symptoms.

Authors:  Akanchha Kesari; Robert Neel; Lynne Wagoner; Brennan Harmon; Christopher Spurney; Eric P Hoffman
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.